UPMC led global trial fast tracks testing of hydroxychloroquine, other COVID-19 therapies
by Press Release from Outbreak News Today on (#51Z0G)
A novel clinical trial developed by researchers at the University of Pittsburgh School of Medicine launched today at UPMC to address one of the most important debates during the COVID-19 pandemic: How should doctors decide between quickly adopting new therapies, such as the anti-malarial drug hydroxychloroquine, and waiting until they are tested in longer clinical ["]
The post UPMC led global trial fast tracks testing of hydroxychloroquine, other COVID-19 therapies appeared first on Outbreak News Today.